Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis

Cancer Research

Volumn 73, Issue 13, 2013, Pages 4086-4097

  Teitz, Tal ^a   Inoue, Madoka ^a   Valentine, Marcus B ^a   Zhu, Kejin ^a   Rehg, Jerold E ^a   Zhao, Wei ^a   Finkelstein, David ^a   Wang, Yong Dong ^b   Johnson, Melissa D ^a   Calabrese, Christopher ^a   Rubinstein, Marcelo ^c   Hakem, Razqallah ^d   Weiss, William A ^e   Lahti, Jill M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Hartwell Center for Bioinformatics and Biotechnology   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MESSENGER RNA; MICRORNA; MICRORNA 29B; MICRORNA 7A; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW METASTASIS; CASPASE 8 GENE; CELL MOTILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE AMPLIFICATION; GENE EXPRESSION; INFLAMMATION; MICROARRAY ANALYSIS; MOUSE; MYCN ONCOGENE; NEUROBLASTOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BONE MARROW NEOPLASMS; CASPASE 8; DISEASE MODELS, ANIMAL; GANGLIONEUROBLASTOMA; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTOME;

EID: 84880077732     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-2681     Document Type: Article

References (50)

1. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010;362: 2202-11.
2. Owens C, Irwin M. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 2012;49: 85-115.
3. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009;27: 289-97.
4. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997;16: 2985-95.
5. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3: 203-16.
6. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 1996;85: 817-27.
7. Teitz T, Jiang M, Twitchell D, Lahti JM. Caspase-8 roles in cancer and development - Lessons in multitasking. In Kevin V. Urbano, ed. Advances in Genetic Research, vol. 9. Hauppauge, NY: Nova Publishers; 2012; pp. 55-82.
8. Lee P, Lee D, Chan C, Chen S, Ch'en I, Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature 2009;458: 519-24.
9. Li C, Lasse S, Lee P, Nakasaki M, Chen S, Yamasaki K, et al. Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8. Proc Natl Acad Sci U S A 2010; 107: 22249-54.
10. Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, et al. Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease. Mol Carcinog 2011;50: 153-62.
11. Krelin Y, Zhang L, Kang TB, Appel E, Kovalenko A, Wallach D. Caspase-8 deficiency facilitates cellular transformation in vitro. Cell Death Differ 2008;15: 1350-5.
12. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006;439: 95-9.
13. Raguénez G, Mühlerthaler-Mottet A, Meier R, Duros C, Bénard J, Gross N. Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer 2009;9: 97.
14. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY, et al. Essential role for caspase 8 in T-cell homeostasis and Tcell mediated immunity. Genes Dev 2003;17: 883-95.
15. Gelman DM, Noain D, Avale ME, Otero V, Low MJ, Rubinstein M. Transgenic mice engineered to target Cre/LoxP-mediated DNA recombination into catecholaminergic neurons. Genesis 2003;36: 196-202.
16. Teitz T, Stanke JJ, Federico S, Bradley CL, Brennan R, Zhang J, et al. Preclinical models for neuroblastoma: establishing a baseline for treatment. PLoS ONE 2011;6: e19133.
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-64.
18. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008;14: 1012-7.
19. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003;4: 3.
20. Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, et al. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc Natl Acad Sci U S A 2004;101: 12664-9.
21. Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, et al. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol 2009;175: 856-66.
22. Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC, et al. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000;275: 35565-9.
23. Vitali R, Mancini C, Cesi V, Tanno B, Mancuso M, Bossi G, et al. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin Cancer Res 2008;14: 4622-30.
24. Rogulski KR, Cohen DE, Corcoran DL, Benos PV, Prochownik EV. Deregulation of common genes by c-Myc and its direct target, MTMC1. Proc Natl Acad Sci U S A 2005;102: 18968-73.
25. Yang Q, Liu S, Tian Y, Hasan C, Kersey D, Salwen HR. Methylationassociated silencing of the heat shock Protein 47 gene in human neuroblastoma. Cancer Res 2004;64: 4531-8.
26. Kinoshita M, Nakamura T, Ihara M, Haraguchi T, Hiraoka Y, Tashiro K. Identification of human endomucin-1 and -2 as membrane-bound Osialoglycoproteins with anti-adhesive activity. FEBS Lett 2001; 499: 121-6.
27. Ordway JM, Williams K, Curran T. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 2004;23: 3737-48.
28. Ostler KR, Yang Q, Looney TJ, Zhang L, Vasanthakumar A, Tian Y, et al. Truncated DNMT3B isoform DNMT3B7 supresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma. Cancer Res 2012;72: 4714-23.
29. Tao G, Levay AK, Gridley T, Lincoln J.Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol 2011;359: 209-21.
30. Sprenger CCT, Drivdahl RH, Woodke LB, Eyman D, Reed MJ, Carter WG, et al. Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells. Neoplasia 2008; 10: 1350-61.
31. Huang X, Ji G, Wu Y, Wan B, Yu L. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J Cancer Res Clin Oncol 2008; 134: 705-14.
32. Law EWL, Cheung AKL, Kashuba VI, Pavlova TV, Zabarovsky ER, Lung HL, et al. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2 in nasopharyngeal carcinoma. Oncogene 2012;31: 728-38.
33. Happonen KE, Furst CM, Saxne T, Heinegard D, Blom AM. PRELP protein inhibits the formation of the complement membrane attack complex. J Biol Chem 2012;287: 8092-100.
34. Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, et al. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen-receptor positive and -negative cancers. J Clin Oncol 2010; 28: 4316-23.
35. Stewart DA, Cooper CR, Sikes RA. Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2004;7: 2-15.
36. Qin W, Chung ACK, Huang XR, Meng X, Hui DSC, Yu C, et al. TGFb/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011;22: 1462-74.
37. Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, et al. Suppression of microRNA-29 expression by TGFb-1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012;23: 252-65.
38. Guo J, Dong Q, Fang Z, Chen X, Lu H, Wang K, et al. Identification of microRNAs that are associated with tumor metastasis in neuroblastoma. Cancer Biol Ther 2010;9: 446-52.
39. Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 2012;7: e41523.
40. Grosse-Wilde A, Voloshanenko O, Bailey SL, Longton GM, Schaefer U, Csernok AI, et al. TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 2008;118: 100-10.
41. Fulda S. Caspase-8 in cancer biology and therapy. Cancer Lett 2009;281: 128-33.
42. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012;196: 395-406.
43. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009;9: 108-22.
44. Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol 2009;10: 63-73.
45. Trimboli AJ, Fukino K, Bruin A, Wei G, Shen L, Tanner SM, et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008;68: 937-45.
46. Lahti JM, Teitz T, Stupack DG. Does integrin-mediated cell death confer tissue tropism in metastasis? Cancer Res 2006;66: 5981-4.
47. Anscher MS. Targeting the TGF-b1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 2010;15: 350-9.
48. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, et al. Conversion of mechanical force into TGF-b-mediated biochemical signals. Curr Biol 2011;21: 933-41.
49. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signaling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 2009;11: 1287-96.
50. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughout Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 2010; 13: 133-40.